Navigation Links
Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon

significant proportion of infected individuals, leading to cirrhosis, primary liver cancer, and even death.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. The Company's primary focus is rapid progress toward the commercialization of its two lead compounds, Albuferon(R) for hepatitis C, and LymphoStat-B(R) for lupus. Phase 3 clinical trials of both compounds are now underway.

In June 2006, HGS announced that the U.S. Government exercised its option under an existing contract to purchase 20,000 doses of ABthrax(TM) for the treatment of anthrax disease. Other HGS drugs in clinical development include two TRAIL receptor antibodies for the treatment of hematopoietic and solid malignancies, in addition to an antibody to the CCR5 receptor for the treatment of HIV/AIDS.

For more information about HGS, please visit the Company's web site at www.hgsi.com. For more information about Albuferon, please visit http://www.hgsi.com/products/albuferon.html. Health professionals or patients interested in Albuferon clinical trials or other studies involving HGS products may inquire via the Contact Us section of the Company's web site, www.hgsi.com/products/request.html, or by calling us at (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
5. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
6. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
9. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
10. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model

Post Your Comments:
(Date:11/6/2009)..., RESEARCH TRIANGLE PARK, N.C., Nov. 6 /PRNew...any advancing orally-available antiviral therapeut...d updates on the development of the company,s lead...rganization (WHO) and the Global Health Security I...viral agent being developed for the treatment of s...
(Date:11/6/2009)..., DETROIT, Nov. 6 C...: CPD ) has launched ketorolac tromethamine ophth...om the US Food and Drug Administration (FDA) for S...) for generic Acular® opthalmic solution on t...ength of ketorolac is therapeutically equivalent t...
(Date:11/5/2009)..., SAN DIEGO, Nov. 5 Althea T...nt and manufacturing services for biopharmaceutica...rmulation Development to the company,s platform of...ointed Dr. James Matsuura, Director of Formulation...am of formulation and analytical scientists, along...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2iTech Medical Provides Update on MPR Clinical Development Plan 58632 1iTech Medical Provides Update on MPR Clinical Development Plan 58632 2iTech Medical Provides Update on MPR Clinical Development Plan 58632 3iTech Medical Provides Update on MPR Clinical Development Plan 58632 4Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 1Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 2Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 3Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 4Prix Galien USA Honors Innovation in Science and Biotech Industries 5128 1Prix Galien USA Honors Innovation in Science and Biotech Industries 5128 2
...xin Demonstrates Promising Clinical Activity in Pa...t Cancers -, SOUTH SAN FRANCISCO, Calif., Nov. 6 ...esented data from three clinical,trials of the com...S-595),at the Chemotherapy Foundation Symposium he...esented from Phase 1 and Phase 1b/2 studies in pat...
...Study of Its Kind, PASADENA, Calif., Nov. 4 Proa... average of 37.2 percent -- and as much as 50,perc...onducted by Kaiser,Permanente Southern California....he Journal of Bone & Joint Surgery, a peer-reviewe...ve-year study tracked more than,625,000 male and f...
Other Medicine Technology:Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 2Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 3Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 4Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 5Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds 2Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds 3Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds 4
(Date:11/8/2009)...ov. 7 Today, the House ...r, Dahlkemper, Smith, Ellsworth and Lipinski amend...t" (H.R. 3962). The amendment maintains the curren...n and for benefits packages that include abortion....eive affordability credits and those who do not, c...
(Date:11/8/2009)...ov. 7 USAction this eve...for America Act, which will make health care more ... accountable and increase access to health care fo..., "Teddy Roosevelt, FDR and Harry Truman would ...rney. "Today,s vote ranks among our country,s prou...
(Date:11/8/2009)...ov. 8 The following was...ion Rescue Insurrecta Nex. ,, Mr. Terry and hi...hting to keep child-killing by abortion out of any...es: "This is a great first step to victory -- a to...of fighting ahead of us. Our rejoicing must be tem...
(Date:11/8/2009)... House Passage of Health Care Reform Bill ,, ...prove coverage for all Americans ,, BALTIMORE,...ght the United States House of Representatives pas...ould strengthen Medicare for seniors and end discr...ons of Americans out of affordable health coverage...
(Date:11/7/2009)... Nov. 7 Speaker Nancy...of H.R. 3962, the Affordable Health Care for Ameri...ter tonight. Below are the Speaker,s remarks. ,...istoric moment for our nation and for American fam...ty and political philosophy -- as far back as Tedd...
Breaking Medicine News(10 mins):Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
... Comes a Year Early to Help Combat Vets, PHILADEL...ames B. Peake today said an expansion by the Depar... which provide readjustment,counseling and outreac...years. Fifteen of those centers are already operat...
...ubstantiates Marketability of Propess(R) --, PLYM...BMP Sunstone,Corporation (Nasdaq: BJGP ) (,BMP Su...opess(R) was recommended by the Obstetrics Group a...he Guidelines for Labor Induction in Late-Stage Pr...
...ounced that, based on input from the AGA Institute...sts, it will not implement Clinical Policy Bulleti...ould have restricted the use of an anesthesia prof...alf of AGA members to express concern that this po...
...na didn,t make it to Vietnam, Thailand, study find...-- Several strains of H5N1 bird flu virus that aff...eighboring Thailand and Vietnam, say University of...alysis may help scientists better understand how t...
...Feb. 27 Rising concerns about potential,skin dama...roducts among,health-conscious American women who ..., whitening products are flying off the shelves as...s represent significant growth opportunities for c...
.... 27 Medication Management Systems,(MMS), a leadi...out the,U.S., today announced the appointment of N...ecutive position of President and Chief Operating ...logies that promote efficacy, safety, and adherenc...
Other Medicine News:Health News:VA Has Added 20 New Vet Centers 2Health News:BMP Sunstone's Propess(R) Recommended as First Line Treatment By the Chinese Medical Association 2Health News:BMP Sunstone's Propess(R) Recommended as First Line Treatment By the Chinese Medical Association 3Health News:AGA Institute applauds delay of Aetna sedation restrictions 2Health News:Some Countries May Have Slowed Bird Flu's Spread 2Health News:Health and Fashion - Dow Corning Predicts the Top Trends Driving Consumers to the Beauty Counters 2Health News:Medication Management Systems Names New President and COO 2
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: